This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology
- 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
- Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices
- A Tabulated Summary of the FDG PET Literature
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors